Try our corporate solution for free!

Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2022

Published by
Sanyukta Kanwal,
Sep 12, 2022
In fiscal year 2022, Aurobindo Pharma's net debt to EBITDA ratio was negative 0.58, down from fiscal year 2020. The net profit of the pharmaceutical company before taxes was over 26 billion Indian rupees in financial year 2021.

Net debt to EBITDA ratio of Aurobindo Pharma Limited from financial year 2013 to 2022

Exclusive Premium statistic

You need a Statista Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Statista Accounts
View for free

Access to this and all other statistics on 80,000 topics from

$468 USD / Year
$708 USD / Year

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

July 2022

Region

India

Survey time period

FY 2013 to FY 2022

Supplementary notes

EBITDA refers to earnings before interest, tax, depreciation and amortization. Financial analysts use the net debt to EBITDA ratio to determine a company’s ability to pay its debt. A high ratio of net debt to EBITDA reveals a company that is deep in debt and vice versa for a low ratio.

*Includes higher sales from limited competition product.

India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on " GlaxoSmithKline Pharmaceuticals Limited India "

The most important statistics
The most important statistics
The most important statistics

Statistics on GlaxoSmithKline Pharmaceuticals Limited India

Overview

8

Key figures

6

Major players

5

Further related statistics

14

Further Content: You might find this interesting as well

Statistics

Topics

Merck & Co.Global pharmaceutical industryPharmaceutical industry in the U.S.PfizerNovartis
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu